Featured Research

from universities, journals, and other organizations

Alzheimer's Disease: Newly Found Peptide Offers Hope Of Early Test And Better Treatment

Date:
June 10, 2009
Source:
Wiley-Blackwell
Summary:
Researchers in Japan have detected a peptide in cerebrospinal fluid that can show whether a person is developing Alzheimer's disease. Measuring the level of this peptide could show that the disease process has started, long before any serious damage is done to the brain.

Researchers in Japan have detected a peptide in cerebrospinal fluid (CSF) that can show whether a person is developing Alzheimer's disease. Measuring the level of this peptide could show that the disease process has started, long before any serious damage is done to the brain.

Related Articles


This research raises new opportunities for combating Alzheimer's disease. Currently treatments can only be started after considerable structural damage has occurred in the person's brain. However, if this finding is broadly used as a clinical test, treatment may be possible before too much damage is present, offering the hope of much better outcomes.

"This novel peptide is the long-sought surrogate marker for Alzheimer's disease," says lead researcher Masayasu Okochi, who works in the Department of Neuropsychiatry at Osaka University Graduate School of Medicine, Japan.

Treating Alzheimer's disease is complex for a number of reasons. First, there are few or no signs that a person has the disease until the destructive process has been active in the person's brain for many months or years. Second, once the damage is done in the brain, it is difficult to restore lost function.

Consequently, many people are trying to find ways of detecting the onset of Alzheimer's disease long before any symptoms appear. In addition, they want to use a sampling method that does not involve costly scanning equipment.

The multi-centre Japanese team analysed CSF and brain tissue samples from people with and without diagnosis of Alzheimer's disease. They discovered that increases in levels of their newly identified peptide (APL1beta28) reflected increased production of Abeta42 in the brain. While Abeta42 is always produced in the brain, this peptide is one of the key constituents of the senile plaques that play a critical role in Alzheimer's disease, and increased production is associated with plaque formation.

"Many pharmaceutical companies are developing Abeta-targeting compounds that could prevent some of the brain damage associated with Alzheimer's disease, but their use will be limited if given after symptoms appear. Our new test allows early diagnosis, giving patients the chance of getting maximum benefit from these new drugs," says Okochi.


Story Source:

The above story is based on materials provided by Wiley-Blackwell. Note: Materials may be edited for content and length.


Journal Reference:

  1. Yanagida.K, Okochi.M, et al. The 28-amino acid form of an APLP1-derived Abeta-like peptide is a surrogate marker for Abeta42production in the central nervous system. EMBO Mol. Med., 2009 1(4) DOI: 10.1002/emmm.200900026

Cite This Page:

Wiley-Blackwell. "Alzheimer's Disease: Newly Found Peptide Offers Hope Of Early Test And Better Treatment." ScienceDaily. ScienceDaily, 10 June 2009. <www.sciencedaily.com/releases/2009/06/090609220551.htm>.
Wiley-Blackwell. (2009, June 10). Alzheimer's Disease: Newly Found Peptide Offers Hope Of Early Test And Better Treatment. ScienceDaily. Retrieved February 1, 2015 from www.sciencedaily.com/releases/2009/06/090609220551.htm
Wiley-Blackwell. "Alzheimer's Disease: Newly Found Peptide Offers Hope Of Early Test And Better Treatment." ScienceDaily. www.sciencedaily.com/releases/2009/06/090609220551.htm (accessed February 1, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, February 1, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Hikers Rescued After Fall from Oregon Mountain

Hikers Rescued After Fall from Oregon Mountain

AP (Feb. 1, 2015) Two climbers who were hurt in a fall on Mount Hood are now being treated for their injuries. Rescue officials say they were airlifted off the mountain Saturday afternoon by an Oregon National Guard helicopter. (Feb. 2) Video provided by AP
Powered by NewsLook.com
Smart Glasses Augment Reality to Help Visually Impaired

Smart Glasses Augment Reality to Help Visually Impaired

Reuters - Innovations Video Online (Feb. 1, 2015) New augmented reality smart glasses developed by researchers at Oxford University can help people with visual impairments improve their vision by providing depth-based feedback, allowing users to "see" better. Joel Flynn reports. Video provided by Reuters
Powered by NewsLook.com
Flu Season Hitting Elderly Hard

Flu Season Hitting Elderly Hard

Reuters - US Online Video (Jan. 31, 2015) The CDC says this year&apos;s flu season is hitting people 65 years of age and older especially hard. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
CDC: Get Vaccinated for Measles

CDC: Get Vaccinated for Measles

Reuters - US Online Video (Jan. 30, 2015) The CDC is urging people to get vaccinated for measles amid an outbreak that began at Disneyland and has now infected more than 90 people. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins